A startup using regenerative medicine technologies to produce and supply homogeneous, high-precision blood cells at scale. It streamlines infectious disease research and the evaluation of pharmaceuticals and functional materials for efficacy and safety, while also providing research cells, testing cells, and diagnostic kits.
[画像: https://prtimes.jp/i/55964/3/resize/d55964-3-0c0cf85cdee7484e8db4-0.jpg ] ■受賞概要 当社は、再生医療技術を用いてヒトiPS細胞などから誘導した不死化ミエロイド系細胞（Mylc細胞：免疫細胞の一...
[画像: https://prtimes.jp/i/55964/2/resize/d55964-2-ff514c86260ac62f672a-0.jpg ] マイキャン・テクノロジーズ株式会社 (本社：京都府京都市、代表取締役：宮崎 和雄) は、国立研究開発法人 新エネルギー・...
[画像: https://prtimes.jp/i/55964/1/resize/d55964-1-65f8b292b1973b3cf657-0.png ] マイキャン・テクノロジーズ株式会社 (本社：京都府京都市、代表取締役：宮崎 和雄) は、リアルテックファンド3号投資事...
Leveraging ocean data to provide information services for fisheries and marine industries. A startup supporting fisheries efficiency and sustainable resource utilization, contributing to building a prosperous ocean for the future.
Providing AI agents specialized for the construction industry. Supporting field and office operations to enhance efficiency and decision-making. A startup offering optimized support for construction tasks through its proprietary generation engine.
Our mission is to safeguard the health of people worldwide. We are an Osaka University-spun-off healthcare startup in the healthcare/preventive medicine field, developing and providing the “Blood Vessel Beauty” scope—which observes capillary blood flow from the fingertip without blood sampling—along with the capillary image analysis software ‘CAS’ and the cloud-based evaluation system “CAS-Rating.” We research the relationship between capillary data and health/disease risks, aiming to implement new health indicators and preventive medical services in society.
Solving challenges in manufacturing, construction, and infrastructure with proprietary AI that leverages even limited data. A startup supporting operational efficiency and labor savings, aiming for a future where humans and AI coexist.
